Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.56
+0.73 (4.09%)
At close: Jun 26, 2026, 4:00 PM EDT
18.60
+0.04 (0.22%)
After-hours: Jun 26, 2026, 7:47 PM EDT
Relay Therapeutics Employees
Relay Therapeutics had 192 employees as of December 31, 2025. The number of employees decreased by 69 or -26.44% compared to the previous year.
Employees
192
Change (1Y)
-69
Growth (1Y)
-26.44%
Revenue / Employee
$55,316
Profits / Employee
-$1,412,979
Market Cap
4.04B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 507 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
| Parabilis Medicines | 145 |
RLAY News
- 19 days ago - Relay Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Relay Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June - GlobeNewsWire
- 4 weeks ago - Relay Therapeutics price target raised to $26 from $22 at Guggenheim - TheFly
- 4 weeks ago - Relay Therapeutics price target raised to $28 from $25 at H.C. Wainwright - TheFly
- 5 weeks ago - Relay Therapeutics 22.9M share Secondary priced at $12.00 - TheFly
- 5 weeks ago - Relay Therapeutics Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Relay Therapeutics price target raised to $21 from $19 at Citizens - TheFly